OTC Pharmaceuticals - Guinea | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$56.96m in 2024. The market is expected to grow annually by 10.83% (CAGR 2024-2029).
The market's largest segment is the segment Skin Treatment with a market volume of US$14.13m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$3.92 are generated in 2024.
In the OTC Pharmaceuticals market, 3.4% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Guinea is experiencing steady growth due to increasing customer preferences for self-medication and the availability of a wide range of over-the-counter products.

Customer preferences: Customers in Guinea are increasingly opting for self-medication, driven by factors such as convenience, accessibility, and cost-effectiveness. With the growing awareness of common health conditions and the availability of information online, consumers are more inclined to take charge of their own health and seek out OTC products for relief from minor ailments. This shift in consumer behavior is contributing to the growth of the OTC Pharmaceuticals market in Guinea.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Guinea is the rising demand for analgesics and antipyretics. These products, which include pain relievers and fever reducers, are widely used for common ailments such as headaches, muscle aches, and fevers. The increasing prevalence of these health issues, coupled with the ease of access to OTC analgesics and antipyretics, is driving the growth of this segment in the market. Another trend in the market is the growing demand for gastrointestinal medications. Digestive disorders such as indigestion, heartburn, and diarrhea are common among the population in Guinea. As a result, there is a high demand for OTC gastrointestinal medications that provide relief from these symptoms. The availability of a variety of OTC products targeting different gastrointestinal issues is fueling the growth of this segment in the market.

Local special circumstances: One of the local special circumstances in Guinea is the limited access to healthcare facilities, especially in rural areas. This lack of access to professional medical care has led to an increased reliance on self-medication and OTC products. Consumers in these areas often turn to OTC Pharmaceuticals as a first line of defense for common health issues, further driving the growth of the market.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Guinea is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income among the population. As a result, consumers have more purchasing power to spend on healthcare products, including OTC Pharmaceuticals. Additionally, the government has implemented policies to improve healthcare infrastructure and promote the availability of affordable OTC products, further supporting the growth of the market. In conclusion, the OTC Pharmaceuticals market in Guinea is growing due to increasing customer preferences for self-medication, the rising demand for analgesics and antipyretics, and the growing demand for gastrointestinal medications. The limited access to healthcare facilities and the underlying macroeconomic factors of the country also contribute to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.